Tuesday, 30 May 2017

Rohto Pharma invests $5 million in SastaSundar Healthbuddy

NEW DELHI: Japanese firm Rohto Pharmaceutical Co has invested USD 5 million (over Rs 32 crore) to acquire 13 per cent stake in SastaSundar Healthbuddy Ltd. The Indian firm is looking at launching operations in the national capital with plans to expand in 12 states across the country. Read more here: Rohto Pharma invests $5 million in SastaSundar Healthbuddy
Read More Here: Rohto Pharma invests $5 million in SastaSundar Healthbuddy

No comments:

Post a Comment